Evidence map›Paper›PMID 21490975›Full record

ArticlePloS one2011

Cbl enforces Vav1 dependence and a restricted pathway of T cell development.

Jeffrey Chiang, Richard J Hodes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeffrey ChiangExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America. chiangj@mail.nih.gov
Richard J Hodes
National Institutes of Health · US

Funding

Receptor Mediated T and B Cell ActivationZIABC009281 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HODES, RICHARD J. · 2009 to 2023
$8.0M
Intramural NIH HHS
6 · The paper itself

Abstract

Extensive studies of pre-TCR- and TCR-dependent signaling have led to characterization of a pathway deemed essential for efficient T cell development, and comprised of a cascade of sequential events involving phosphorylation of Lck and ZAP-70, followed by phosphorylation of LAT and SLP-76, and subsequent additional downstream events. Of interest, however, reports from our lab as well as others have indicated that the requirements for ZAP-70, LAT, and SLP-76 are partially reversed by inactivation of c-Cbl (Cbl), an E3 ubiquitin ligase that targets multiple molecules for ubiquitination and degradation. Analysis of signaling events in these Cbl knockout models, including the recently reported analysis of SLP-76 transgenes defective in interaction with Vav1, suggested that activation of Vav1 might be a critical event in alternative pathways of T cell development. To extend the analysis of signaling requirements for thymic development, we have therefore assessed the effect of Cbl inactivation on the T cell developmental defects that occur in Vav1-deficient mice. The defects in Vav1-deficient thymic development, including a marked defect in DN3-DN4 transition, were completely reversed by Cbl inactivation, accompanied by enhanced phosphorylation of PLC-γ1 and ERKs in response to pre-TCR/TCR cross-linking of Vav1⁻/⁻Cbl⁻/⁻ DP thymocytes. Taken together, these results suggest a substantially modified paradigm for pre-TCR/TCR signaling and T cell development. The observed consensus pathways of T cell development, including requirements for ZAP-70, LAT, SLP-76, and Vav1, appear to reflect the restriction by Cbl of an otherwise much broader set of molecular pathways capable of mediating T cell development.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBlotting, WesternMembrane ProteinsMiceMice, KnockoutPhosphoproteinsPhosphorylationProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-vavSignal TransductionT-LymphocytesZAP-70 Protein-Tyrosine KinaseAdaptor Proteins, Signal TransducingLat protein, mouseMembrane ProteinsPhosphoproteinsProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-vavSh2d2a protein, mouseSLP-76 signal Transducing adaptor proteinsZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID21490975
PMCPMC3072394
OpenAlexW2076725876

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.